Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 513915, 6 pages
http://dx.doi.org/10.1155/2014/513915
Research Article

The Role of CTLA-4 Exon-1 49 A/G Polymorphism and Soluble CTLA-4 Protein Level in Egyptian Patients with Behçet's Disease

1Rheumatology & Rehabilitation Department, Faculty of Medicine, Zagazig University, Zagazig 44511, Egypt
2Clinical Pathology Department, Faculty of Medicine, Zagazig University, Zagazig 44511, Egypt

Received 25 February 2014; Revised 30 April 2014; Accepted 18 May 2014; Published 2 June 2014

Academic Editor: Bijay Vaidya

Copyright © 2014 Sahar M. Abdel Galil and Hoda A. Hagrass. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Saadoun and B. Wechsler, “Behçet's disease,” Orphanet Journal of Rare Diseases, vol. 7, no. 1, article 20, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. H. Yazıc, S. Yurdakul, and V. Hamuryudan, “Behcet’s syndrome,” Rheumatology, vol. 7, article 26, 1998. View at Google Scholar
  3. N. Sallakci, A. Bacanli, M. Coskun, U. Yavuzer, E. Alpsoy, and O. Yegin, “CTLA-4 gene 49A/G polymorphism in Turkish patients with Behçet's disease,” Clinical and Experimental Dermatology, vol. 30, no. 5, pp. 546–550, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Nishiyama, K. Nakae, T. Kuriyama, M. Hashimoto, and Z.-N. Hsu, “A study among related pairs of Japanese patients with familial Behçet's disease: group comparisons by interval of disease onsets,” Journal of Rheumatology, vol. 29, no. 4, pp. 743–747, 2002. View at Google Scholar · View at Scopus
  5. S. Yilmaz and K. A. Cimen, “Familial Behçet’s disease,” Rheumatology International, vol. 30, pp. 1107–1109, 2010. View at Google Scholar
  6. B. Gülbay, T. Acıcan, and Ö. E. Diken, “Familial Behçet’s disease of adult sge: a report of 4 cases from a Behçet family,” Internal Medicine, vol. 51, pp. 1609–1611, 2010. View at Google Scholar
  7. B. M. Carreno, F. Bennett, T. A. Chau et al., “Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy,” Journal of Clinical Investigations, vol. 108, pp. 895–903, 2001. View at Google Scholar
  8. B. M. Carreno, F. Bennett, T. A. Chau et al., “CTLA-4 (CD152) can inhibit T cell activation by two different mechanisms depending on its level of cell surface expression,” Journal of Immunology, vol. 165, no. 3, pp. 1352–1356, 2000. View at Google Scholar · View at Scopus
  9. P. A. van der Merwe, D. L. Bodian, S. Daenke, P. Linsley, and S. J. Davis, “CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics,” Journal of Experimental Medicine, vol. 185, no. 3, pp. 393–403, 1997. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Kosmaczewska, L. Ciszak, D. Boćko, and I. Frydecka, “Expression and functional significance of CTLA-4, a negative regulator of T cell activation,” Archivum Immunologiae et Therapiae Experimentalis, vol. 49, no. 1, pp. 39–46, 2001. View at Google Scholar · View at Scopus
  11. K. A. Hunt, D. P. B. McGovern, P. J. Kumar et al., “A common CTLA4 haplotype associated with coeliac disease,” European Journal of Human Genetics, vol. 13, no. 4, pp. 440–444, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Vaidya and S. Pearce, “The emerging role of the CTLA-4 gene in autoimmune endocrinopathies,” European Journal of Endocrinology, vol. 150, no. 5, pp. 619–626, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. J. Wang, Y. P. Shi, H. Yue, W. Chun, and L. P. Zou, “CTLA-4 exon 1 +49A/G polymorphism is associated with renal involvement in pediatric Henoch-Schönlein purpura,” Pediatric Nephrology, vol. 27, no. 11, pp. 2059–2064, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. M. K. Oaks and K. M. Hallett, “Cutting edge: a soluble form of CTLA-4 in patients with autoimmune thyroid disease,” Journal of Immunology, vol. 164, no. 10, pp. 5015–5018, 2000. View at Google Scholar · View at Scopus
  15. T. Kouki, Y. Sawai, C. A. Gardine, M. E. Fisfalen, M. L. Alegre, and L. J. DeGroot, “CTLA-4 Gene polymorphism at position 49 in exon 1 reduces the inhibitory function of CTLA-4 and contributes to the pathogenesis of Graves' disease,” Journal of Immunology, vol. 165, no. 11, pp. 6606–6611, 2000. View at Google Scholar · View at Scopus
  16. M. Mäurer, S. Loserth, A. Kolb-Mäurer et al., “A polymorphism in the human cytotoxic T-lymphocyte antigen 4 (CTLA4) gene (exon 1 +49) alters T-cell activation,” Immunogenetics, vol. 54, no. 1, pp. 1–8, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Ligers, N. Teleshova, T. Masterman, W.-X. Huang, and J. Hillert, “CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms,” Genes and Immunity, vol. 2, no. 3, pp. 145–152, 2001. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Davatchi, M. Schirmer, C. Zouboulis, S. Assad-Khalil, and K. T. Calamia, “On behalf international team for the revision of the international criteria for Behcet's disease, evaluation and revision of the international study group criteria for Behçet's disease,” in Proceedings of the American College of Rheumatology Meeting, Boston, Mass, USA, 2007.
  19. I. ben Dhifallah, H. Chelbi, A. Braham, K. Hamzaoui, and M. H. Houman, “CTLA-4 +49A/G polymorphism is associated with Behçet's disease in a Tunisian population,” Tissue Antigens, vol. 73, no. 3, pp. 213–217, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. R. Gunesacar, E. Erken, B. Bozkurt et al., “Analysis of CD28 and CTLA-4 gene polymorphisms in Turkish patients with Behcet's disease,” International Journal of Immunogenetics, vol. 34, no. 1, pp. 45–49, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. Y. H. Lee and G. G. Song, “CTLA-4 polymorphisms and susceptibility to Behcet's disease: a meta-analysis,” Molecular Biology Reports, vol. 39, no. 9, pp. 9041–9045, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. J. Zhang, W. D. Xu, Z. H. Duan, S. S. Liu, H. F. Pan, and D. Q. Ye, “Lack of association between CTLA-4 +49A/G and -318C/T polymorphisms and behçet's disease risk: a meta-analysis,” Clinical and Experimental Rheumatology, vol. 30, no. 72, pp. S46–S50, 2012. View at Google Scholar · View at Scopus
  23. S. Hou, A. Kijlstra, and P. Yang, “The genetics of Behçet’s disease in a Chinese population,” Frontiers of Medicine, vol. 6, no. 4, pp. 354–359, 2012. View at Google Scholar
  24. K. S. Park, J. A. Baek, J. E. Do, D. Bang, and E.-S. Lee, “CTLA4 gene polymorphisms and soluble CTLA4 protein in Behcet's disease,” Tissue Antigens, vol. 74, no. 3, pp. 222–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. L. Bye, N. Modi, M. R. Stanford et al., “CTLA-4 polymorphisms are not associated with ocular inflammatory disease,” Tissue Antigens, vol. 72, no. 1, pp. 49–53, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. S. Hirohata and H. Kikuchi, “Review, Behçet’s disease,” Arthritis Research and Therapy, vol. 5, pp. 139–146, 2003. View at Google Scholar
  27. J. H. Sim, M. J. Park, S. Park et al., “Altered expression of costimu­latory molecules in Behçet’s disease according to clinical activity,” Britich Journal of Dermatology, vol. 164, pp. 1285–1291, 2011. View at Google Scholar
  28. R. Geiss-Friedlander and F. Melchior, “Concepts in sumoylation: a decade on,” Nature Reviews Molecular Cell Biology, vol. 8, no. 12, pp. 947–956, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. K. T. Calamia, F. C. Wilson, M. Icen, C. S. Crowson, S. E. Gabriel, and H. M. Kremers, “Epidemiology and clinical characteristics of behcet's disease in the us: a population-based study,” Arthritis Care and Research, vol. 61, no. 5, pp. 600–604, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. S. B. Cho, S. Cho, and D. Bang, “New insights in the clinical understanding of behçet's disease,” Yonsei Medical Journal, vol. 53, no. 1, pp. 35–42, 2012. View at Publisher · View at Google Scholar · View at Scopus